Hyperin protects against cisplatin-induced liver injury in mice

To evaluate the effect of hyperin in cisplatin-induced liver injury in mice. Mice were pretreated with hyperin at doses of 25 mg/kg and 50 mg/kg, respectively, for six days, and intraperitoneal injection of cisplatin (40 mg/kg) was administrated one hour after the final intragastrication of hyperin....

Full description

Saved in:
Bibliographic Details
Published inActa cirurgica brasileira Vol. 32; no. 8; pp. 633 - 640
Main Authors Niu, Chengwei, Ma, Man, Han, Xiao, Wang, Zimin, Li, Hangyan
Format Journal Article
LanguageEnglish
Published Brazil Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia 01.08.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To evaluate the effect of hyperin in cisplatin-induced liver injury in mice. Mice were pretreated with hyperin at doses of 25 mg/kg and 50 mg/kg, respectively, for six days, and intraperitoneal injection of cisplatin (40 mg/kg) was administrated one hour after the final intragastrication of hyperin. Twenty-four hours later, blood and liver were collected for further research. A single injection of cisplatin (40 mg/kg) for 24 h significantly increased serum alanine and aspartate aminotransferases (ALT/AST) and gamma glutamyl transferase (GGT) activities, whileas hyperin reversed cisplatin-induced such increases. Liver histopathological examination further demonstrated the protection of hyperin against cisplatin-induced liver injury. Further results showed hyperin reversed cisplatin-induced the increase in content of malondialdehyde (MDA) and the decrease in level of total antioxidant capacity (T-AOC) in liver. Moreover, hyperin increased the levels of superoxide dismutase (SOD), catalase (CAT), glutathione (GSH), glutathione peroxidase (GPx), glutathione-s transferase (GST) in cisplatin-induced liver. Hyperin inhibits cisplatin-induced hepatic oxidative stress, which contributes greatly to the amelioration of cisplatin-induced liver injury in mice.
ISSN:0102-8650
1678-2674
0102-8650
DOI:10.1590/s0102-865020170080000005